Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Clinical trial NCT00225147 · COMPLETED

Trial details

NCT number: NCT00225147
Sponsor: Pharming Technologies B.V.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema Angioneurotic Edema

Start date: 2005-07-01
Primary completion: 2009-10-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.